20 Countries with the Most Domestically Listed Companies in the World

In This Article:

In this article, we will look into the 20 countries with the most domestically listed companies in the world. If you want to skip our detailed analysis, you can go directly to the 5 Countries with the Most Domestically Listed Companies in the World.

According to the World Bank, there were 47,926 total domestically listed companies in 2022. Asia and Pacific had the highest share of the total listed companies, with 27,701 companies listed in East Asia and Pacific and 3,306 companies in South Asia in 2022. The APAC region was followed by North America, with 8,186 listed companies.

The trend of regional dominance can also be seen in the Fortune 500 global list of 2023. Asia, Europe, and North America boast a high number of Global 500 companies. In 2023, 142 out of Global 500 companies were from China, followed by the US and Japan. Asian companies on the list were majorly from China, with only a few incorporated out of the country. The US is one of the major headquarters for Global 500 companies due to its advanced economy and well-developed infrastructure, which provides business growth, accessible capital, and a skilled workforce. You can also check out the Top 20 Business Travel Destinations in The World and 20 Highest Paying Countries for Business Analysts.

Rising Initial Public Offering (IPO) Activity

Established domestic companies play a major role in a nation's development. The IPO market serves the purpose of a feeder, allowing companies to access capital and seek broader markets. According to a report by PwC, the United States is expecting a positive market outlook for the first half of 2024. The stocks in the market grew significantly in the first quarter, driven by the technology and AI sector. The IPO market in the region is also on its path to recovery, with a robust pipeline of companies aiming to go public. In the first quarter of 2024, traditional initial public offerings (IPOs) surged. 14 companies went public, out of which 6 companies were from the pharmaceutical and life sciences sectors. These IPOs collectively generated more than $6.5 billion, representing a threefold increase than in Q1 2023. In the first quarter of 2024, the S&P 500 surged 9% quarter to date. This rise can be attributed to the high demand for AI-related stocks. Traditional IPOs increased by 19% in the first quarter, surpassing broader indexes. This performance by the IPOs hints at the revival of the IPO markets.

CG Oncology, Inc. (NASDAQ:CGON) is among the leading pharmaceutical and biotech companies that went public in the first quarter of 2024. It is a leading cancer drug-developing company, focused on bladder cancer treatment. The company announced its IPO, priced at $29 per share on the Nasdaq on January 25, 2024. On January 26, Reuters reported that CG Oncology, Inc. (NASDAQ:CGON) sold 20 million shares and generated $380 million. In its debut, the company's market value soared and reached $1.75 billion, driven by a 52.6% surge in its shares at its opening. As of April 5, CG Oncology, Inc. (NASDAQ:CGON) is valued at $2.70 billion.